Critical appraisal of canakinumab in the treatment of adults and children with cryopyrin-associated periodic syndrome (CAPS)

References

• AksentijevichIPutnamCDRemmersEFThe clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin modelArthritis Rheum2007561273128517393462
   PubMed Web of Science ®Google Scholar
• KileRLRuskHAA case of cold urticaria with an unusual family historyJAMA194011410671068
   Google Scholar
• HoffmanHMuellerJBrodieDMutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndromeNat Genet20012930130511687797
   PubMed Web of Science ®Google Scholar
• HoffmanHMWandererAABroideDHFamilial cold autoinflammatory syndrome: phenotype and genotype of an autosomal dominant periodic feverJ Allergy Clin Immunol200110861562011590390
   PubMed Web of Science ®Google Scholar
• MuckleTJWellsMUrticaria, deafness and amyloidosis: a new heredo-familial syndromeQJ Med196231235248
   PubMedGoogle Scholar
• HawkinsPNLachmannHJAgannaEMcDermottMFSpectrum of clinical features in Muckle-Wells syndrome and response to anakinraArthritis Rheum20045060761214872505
   PubMed Web of Science ®Google Scholar
• PrieurAMGriscelliGArthropathy with rash, chronic meningitis, eye lesions and mental retardationJ Pediatr19819979837252669
   PubMed Web of Science ®Google Scholar
• FeldmannJPrieurAMQuartierPChronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytesAm J Hum Genet20027119820312032915
   PubMed Web of Science ®Google Scholar
• AksentijevichINowakMMallahMDe novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseasesArthritis Rheum2002463340334812483741
   PubMed Web of Science ®Google Scholar
• DinarelloCAMutations in cryopyrin: bypassing roadblocks in the caspase-1 inflammasome for IL-1β secretion and disease activityArthritis Rheum2007562817282217763412
   PubMed Web of Science ®Google Scholar
• GattornoMTassiSCartaSPattern of IL-1β secretion on response to lipopolysaccharide and ATP before and after IL-1 blockade in patients with CIAS1 mutationsArthritis Rheum2007563138314817763411
   PubMed Web of Science ®Google Scholar
• HoffmanHMRosengrenSBoyleDLPrevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonistLancet20043641779178515541451
   PubMed Web of Science ®Google Scholar
• LeslieKSLachmannHJBruningEPhenotype, genotype, and sustained response to anakinra in 22 patients with autoinflammatory disease associated with CIAS-1/NALP3 mutationsArch Dermatol20061421591159717178985
   PubMed Web of Science ®Google Scholar
• GerardSle GoffBMaugarsYLasting remission of a Muckle-Wells syndrome with CIAS-1 mutation using half-dose anakinraJoint Bone Spine20077465917892965
   PubMed Web of Science ®Google Scholar
• DalgicBEgritasOSariSCuissetLA variant Muckle-Wells syndrome with a novel mutation in CIAS1 gene responding to anakinraPediatr Nephrol2007221391139417486372
   PubMed Web of Science ®Google Scholar
• MaksimovicLStimemannJCauxFNew CIAS1 mutation and anakinra efficacy in overlapping of Muckle-Wells and familial cold autoinflammatory syndromesRheumatology20084730931018174231
   PubMed Web of Science ®Google Scholar
• Kuemmerle-DeschnerJBBialkowskiATzaribachevNKotterIAnakinra in Muckle-Wells syndrome (MWS) – experience up to 29 months [abstract]Clin Exp Rheumatol200826204
   Web of Science ®Google Scholar
• Goldbach-ManskyRShroffSDWilsonMA pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 Trap) in patients with familial cold autoinflammatory syndromeArthritis Rheum2008582432244218668591
   PubMed Web of Science ®Google Scholar
• HoffmanHMThroneMLAmarNJEfficacy and safety of rilonacept (interleukin-1 trap) in patients with cryopyrin-associated periodic syndromesArthritis Rheum2008582443245218668535
   PubMed Web of Science ®Google Scholar
• LachmannHJKone-PautIKuemmerle-DeschnerJBfor the Canakinumab in CAPS Study GroupUse of canakinumab in the cryopyrin-associated periodic syndromeN Engl J Med20093602416242519494217
   PubMed Web of Science ®Google Scholar
• RynneMMacleanCBybeeAHearing improvement in a patient with variant Muckle-Wells syndrome in response to interleukin 1 receptor antagonismAnn Rheum Dis20066553353416531551
   PubMed Web of Science ®Google Scholar
• MiraultTLaunayDCuissetLRecovery from deafness in a patient with Muckle-Wells syndrome treated with anakinraArthritis Rheum2006541697170016646042
   PubMed Web of Science ®Google Scholar
• YamazakiTMasumotoJAgematsuKAnakinra improves sensory deafness in a Japanese patient with Muckle-Wells syndrome, possibly by inhibiting the cryopyrin inflammasomeArthritis Rheum20085886486818311804
   PubMed Web of Science ®Google Scholar
• FedericoGRiganteDPuglieseALEtanercept induces improvement of arthropathy in chronic infantile neurological cutaneous articular (CINCA) syndromeScand J Rheumatol20033231231414690147
   PubMed Web of Science ®Google Scholar
• LovellDJBowyerSLSolingerAMInterleukin-1 blockade by anakinra improves clinical symptoms in patients with neonatal-onset multisystem inflammatory diseaseArthritis Rheum2005521283128615818707
   PubMed Web of Science ®Google Scholar
• RiganteDAnsuiniVCaldarelliMHydrocephalus in CINCA syndrome treated with anakinraChilds Nerv Syst20062233433716525848
   PubMed Web of Science ®Google Scholar
• FrenkelJWulffrattNMKuisWAnakinra in mutation-negative NOMID/CINCA syndrome: comment on the articles by Hawkins et al. and Hoffman and PatelArthritis Rheum2004503738373915529342
   PubMed Web of Science ®Google Scholar
• Goldbach-ManskyRDaileyNJCannaSWNeonatal-onset multisystem inflammatory disease responsive to interleukin-1 beta inhibitionN Engl J Med200635558159216899778
   PubMed Web of Science ®Google Scholar
• LachmannHJLowePDaniela FelixSIn vivo regulation of interleukin-1 beta in patients with cryopyrin-associated periodic syndromesJ Exp Med20092061029103619364880
   PubMed Web of Science ®Google Scholar
• ChurchLDMcDermottMFCanakinumab, a fully-human mAb against IL-1β for the potential treatment of inflammatory disordersCurr Opin Mol Ther200911818919169963
   PubMed Web of Science ®Google Scholar
• Novartis: Ilaris prescribing information: http://www.pharma.us.novartis.com/product/pi/pdf/ilaris.pdf Accessed Feb 17, 2010.
   Google Scholar
• Kuemmerle-DeschnerJBTzaribachevNHansmannSLong-lasting response to ACZ885 (a new human IgG1 anti-IL-1β monoclonal antibody) in patients with Muckle-Wells Syndrome (MWS) [abstract]Clin Exp Rheumatol200826180
   Web of Science ®Google Scholar
• LachmanHJungTFelixSTreatment of cryopyrin associated periodic fever syndrome with a fully human anti-IL1beta monoclonal antibody (ACZ885): results from a subcutaneous administration study [abstract]Clin Exp Rheumatol200826181
   Web of Science ®Google Scholar
• Kuemmerle-DeschnerJBLachmannHJHachullaEEfficacy and safety of canakinumab (Ilaris) in a large cohort of patients across different severity phenotypes of cryopyrin associated periodic syndrome (CAPS) [abstract]Arthritis Rheum200960Suppl 101235
   Google Scholar
• Kuemmerle-DeschnerJBCartwrightRGattornoMSafety and efficacy of canakinumab (Ilaris) in children across different disease severity phenotypes of cryopyrin associated periodic syndrome (CAPS): interim results of an ongoing study [abstract]Arthritis Rheum200960Suppl 102056
   Google Scholar
• ThorntonBDHoffmanHMBhatADonBRSuccessful treatment of renal amyloidosis due to familial cold autoinflammatory syndrome using an interleukin 1 receptor antagonistAm J Kidney Dis20074947748117336710
   PubMed Web of Science ®Google Scholar
• PaulSMHildenbrandHJainMSFunctional outcomes of one year of treatment of neonatal-onset multisystem inflammatory disease (NOMID) with Anakinra [abstract]Arthritis Rheum200756SupplS291
   Google Scholar
• LachmannHJKone-PautIKuemmerle-DeschnerJImproved health-related quality of life in patients with cryopyrin-associated periodic fever syndrome (CAPS) after treatment with canakinumab (Ilaris), a fully human anti-IL-1β monoclonal antibody [abstract]Arthritis Rheum200960Suppl 101482
   Google Scholar